
GE HealthCare Science Chief Taha Kass-Hout Resigns
The company's chief science and technology officer will leave his post effective December 31, 2026.

The company's chief science and technology officer will leave his post effective December 31, 2026.
October 28, 2026
Syntax Bio Programs Stem Cells in Four DaysThe Chicago biotech firm uses its Cellgorithm platform to create pancreatic beta cells rapidly.
October 15, 2026
LanzaJet Secures 20 Million Dollars in New FinancingThe Chicago-based sustainable fuel firm aims to expand operations at its Georgia production facility.
September 21, 2026
Tempus AI and Recursion Pharmaceuticals Extended PartnershipThe companies have updated their data licensing agreement with a new three-year financial commitment.